Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma

28 Nov 2023

Abstract excerpt

BACKGROUND: Cantharidin (CTD) is the active ingredient of Chinese medicine, which has been traditionally used in multiple cancers treatment, especially in hepatocellular carcinoma (HCC). However, a comprehensive analysis of the CTD-related molecular mechanism is still necessary to understand its functions in HCC treatment. This study aimed to reveal the novel molecular targets and regulatory networks of CTD in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Medicinal Plant Pharmacodynamics Research
Share to Natural Compounds in Disease Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38017425
DOI: 10.1186/s12885-023-11594-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinomaPMID 38017425Read ↗

The mechanism of CPT1A involved in hepatocellular carcinoma growth and Bufalin regulates malignant behavior of hepatocellular carcinoma via CPT1ASemantic proximity Read ↗

The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFRSemantic proximity Read ↗

Revealing the Immune Mechanisms of SJZT- Treated HCC via a Systematic Study of Network Pharmacology and Machine LearningSemantic proximity Read ↗

LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinomaSemantic proximity Read ↗

In-silico Identification of Potential Therapeutic Targets against Virus Induced Hepatocellular CarcinomaSemantic proximity Read ↗

Single-Cell RNA Sequencing, Cell Communication, and Network Pharmacology Reveal the Potential Mechanism of Senecio scandens Buch.-Ham in Hepatocellular Carcinoma InhibitionSemantic proximity Read ↗

Network pharmacological analysis of corosolic acid inhibits hepatocellular carcinoma progression through P4HA2Semantic proximity Read ↗

Transcriptomic Insights into the Antitumor Mechanism of Bufalin in Hepatocellular Carcinoma Cell HepG2Semantic proximity Read ↗

Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinomaSemantic proximity Read ↗

Exosome-Related FTCD Facilitates M1 Macrophage Polarization and Impacts the Prognosis of Hepatocellular CarcinomaSemantic proximity Read ↗

Systematic Analysis of the Aberrances and Functional Implications of UPR in Hepatocellular CarcinomaSemantic proximity Read ↗

Mechanisms of Cynarine for treatment of Non-alcoholic Fatty Liver Disease Based on the Integration of Network Pharmacology, Molecular Docking and Cell ExperimentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.